Immune response to simulated postexposure rabies booster vaccinations in volunteers who received preexposure vaccinations.

Several studies of the efficacy of intradermal postexposure rabies vaccination have shown that this procedure is safe, effective, and cost saving. Less is known about the reliability of the present World Health Organization (WHO)-approved intradermal preexposure regimen, which consists of three 0.1-mL doses that are generally given on days 0, 7, and 28. Previous studies have shown that neutralizing antibody responses are lower and of shorter duration in subjects given the reduced-dose intradermal regimen. Thus, it is still uncertain whether the WHO-recommended single intramuscular or intradermal booster injections given on days 0 and 3 would prevent death in all cases. In this preliminary study, we evaluated titers of neutralizing antibody in Thai student volunteers given two simulated postexposure boosters, as recommended by WHO, and we compared these volunteers to a group given vaccine intramuscularly. We observed a lower, although adequate, accelerated immune response in those given the preexposure series and postexposure boosters intradermally.

[1]  H. Wilde,et al.  Rabies in Thailand , 1998, Epidemiology and Infection.

[2]  P. Khawplod,et al.  Immune response to tissue culture rabies vaccine in subjects who had previous postexposure treatment with Semple or suckling mouse brain vaccine. , 1996, Vaccine.

[3]  V. Sitprija,et al.  What is an acceptable delay in rabies immune globulin administration when vaccine alone had been given previously? , 1996, Vaccine.

[4]  P. Khawplod,et al.  Immunogenicity of purified duck embryo rabies vaccine (Lyssavac-N) with use of the WHO-approved intradermal postexposure regimen. , 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[5]  S. Cryz,et al.  Efficacy study of a new albumin-free human diploid cell rabies vaccine (Lyssavac-HDC, Berna) in 100 severely rabies-exposed Thai patients. , 1995, Vaccine.

[6]  S. Sirivichayakul,et al.  Should travellers in rabies endemic areas receive pre-exposure rabies immunization? , 1994, Annales de medecine interne.

[7]  E. Kreuzfelder,et al.  Current and future immunoprophylaxis against human rabies: reduction of treatment failures and errors. , 1994, Current topics in microbiology and immunology.

[8]  P. Khawplod,et al.  Immune response to rabies vaccine in Alaskan dogs: failure to achieve a consistently protective antibody response. , 1993, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[9]  J. Schwenke,et al.  Longevity of rabies antibody titre in recipients of human diploid cell rabies vaccine. , 1992, Vaccine.

[10]  D. Fishbein,et al.  One-year study of the 2-1-1 intramuscular postexposure rabies vaccine regimen in 100 severely exposed Thai patients using rabies immune globulin and Vero cell rabies vaccine. , 1991, Vaccine.

[11]  S. Chutivongse,et al.  Rabies in Thailand: 1990. , 1991, Reviews of infectious diseases.

[12]  D. Fishbein,et al.  Postexposure prophylaxis for rabies with antiserum and intradermal vaccination , 1990, The Lancet.

[13]  N. Ajjan,et al.  Experience with preexposure rabies vaccination. , 1988, Reviews of infectious diseases.

[14]  P. Phanuphak,et al.  An effective economical intradermal regimen of human diploid cell rabies vaccination for post-exposure treatment. , 1986, Clinical and experimental immunology.

[15]  V. Wagner,et al.  Human diploid cell rabies vaccine: retention of immunogenicity after reconstruction. , 1986, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[16]  D. Warrell,et al.  ECONOMICAL MULTIPLE-SITE INTRADERMAL IMMUNISATION WITH HUMAN DIPLOID-CELL-STRAIN VACCINE IS EFFECTIVE FOR POST-EXPOSURE RABIES PROPHYLAXIS , 1985, The Lancet.

[17]  P. Yager,et al.  A rapid reproducible test for determining rabies neutralizing antibody. , 1973, Bulletin of the World Health Organization.